Cysteine protease inhibitor Balicatib, Purity ≥98%

Cat. No.: X24-07-ZQ727

Cysteine protease inhibitor Balicatib, Purity ≥98%

Synonym: 354813-19-7; Cysteine protease inhibitor; AAE581; AAE-581; AAE 581

  • MDL: MFCD19443790
  • CAS Number: 354813-19-7
  • Compound CID: 10201696
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Balicatib, soluble in DMSO and ethanol and insoluble in water, obstructs cysteine proteases, enzymes implicated in numerous diseases due to their role in protein degradation. It targets cathepsin B, cathepsin K, cathepsin L, and cathepsin S.
Molecular Weight
411.54
Molecular Formula
C23H33N5O2
Targets
Cathepsin B: 61 nM; cathepsin K: 22 nM; cathepsin L: 48 nM; Cathepsin S: 2900 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 72 mg/mL (174.95 mM); Water: Insoluble; Ethanol: 3 mg/mL (7.28 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Balicatib is used to research its effect on cysteine proteases, particularly cathepsins, in osteoclast-related bone diseases.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0